ultromics

Archive
Ross Upton, PhD, chief executive and founder of Ultromics
11 August 2025

Ultromics secures £41m Series C funding to expand AI solution

Ultromics, a provider of AI-driven cardiology solutions, has raised $55m (£41m) in Series C financing to scale its technology across
Read More
Coffee Time Briefing
29 July 2025

Digital Health Coffee Time Briefing ☕

This Coffee Time includes OX.DH achieving compliance with the NHSE Tech Innovation Framework and a report on clinicians' attitude towards
Read More
9 May 2023

Ultromics granted FDA Breakthrough Device Status

Ultromics has gained FDA Breakthrough Device Designation for its AI-powered EchoGo Amyloidosis platform, which is speeding up diagnosis.
Read More
29 May 2018

Ultromics AI platform to expand trials to 20 NHS hospitals

A British AI platform for assisting with the diagnosis of heart disease will enter trials with 20 NHS hospitals before
Read More